Physician profile
Andrea Staack
NPI 1578705208
$3,510.36
in general payments reported to CMS, 2019-2025
11 companies · $362 in 2025
The $362 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $533 · 2021: $617 · 2022: $982 · 2023: $355 · 2024: $509 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,225.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,061.15 | 2021-2025 | Interstim, Altaviva |
| Medtronic USA, INC. | $359.05 | 2020 | |
| Allergan, INC. | $309.51 | 2019-2022 | |
| Abbvie INC. | $244.48 | 2022-2025 | Botox |
| Boston Scientific Corporation | $156.85 | 2020-2025 | Axonics |
| Valencia Technologies Corporation | $148.38 | 2022-2024 | Ecoin Device Kit |
| Femselect INC. | $91.49 | 2025 | Enplace |
| Coloplast Corp | $65.51 | 2021-2022 | |
| Axonics, INC. | $34.84 | 2021 | |
| Pelvital USA, INC. | $20.61 | 2025 | |
| Astellas Pharma Global Development | $18.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Staack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.